Up next

Autoplay

CDK 4/6 Inhibitors in Metastatic Breast Cancer

1 Views • 07/03/23
Share
Embed
administrator
administrator
Subscribers
0

Hope S. Rugo, MD, discusses the use of CDK 4/6 inhibitors and their impact on the treatment paradigm for metastatic breast cancer.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay